United Kingdom Biotechnology & Medical Research

Barinthus Biotherapeutics PLC (BRNS)

Track

Track

Barinthus Biotherapeutics PLC has recorded no insider trading activity within the past three months. The most recent transactions occurred in June 2023, involving share purchases by Joseph Scheeren and Robin Wright. Prior to these acquisitions, various executives executed multiple sales throughout 2022 and early 2023.
Ticker: BRNS Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Barinthus Biotherapeutics PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.0
Scheeren Joseph Non-Executive Director
Transaction date
Purchase
Price
226.61
Quantity 6,091 -25.3%
Value US$3,306,075
1.1
Wright Robin Non-Executive Director
Transaction date
Purchase
Price
478.44
Quantity 22,569 +17.7%
Value US$4,845,817
2.2
Enright William Chief Executive Officer Executive Director
Transaction date
Sale
Price
118.49
Quantity 5,740 +43.8%
Value US$4,293,377
4.0
Ellis Christopher Chief Operating Officer Officer
Transaction date
Sale
Price
7.07
Quantity 25,000 -99.7%
Value US$176,708
4.0
Ellis Christopher Chief Operating Officer Officer
Transaction date
Sale
Price
5.69
Quantity 14,176 -36.1%
Value US$80,688
4.0
Griffiths Graham Chief Business Officer Officer
Transaction date
Sale
Price
7.39
Quantity 10,000 -8.8%
Value US$73,870
4.0
Ellis Christopher Chief Operating Officer Officer
Transaction date
Sale
Price
4.78
Quantity 450 -85.7%
Value US$2,152
4.0
Ellis Christopher Chief Operating Officer Officer
Transaction date
Sale
Price
4.84
Quantity 2,175 -96.7%
Value US$10,531
4.0
Ellis Christopher Chief Operating Officer Officer
Transaction date
Sale
Price
4.77
Quantity 649 -89.6%
Value US$3,093
4.0
Griffiths Graham Chief Business Officer Officer
Transaction date
Sale
Price
4.76
Quantity 500 -0.4%
Value US$2,381
4.0
Griffiths Graham Chief Business Officer Officer
Transaction date
Sale
Price
4.82
Quantity 1,220 -1.1%
Value US$5,876
4.0
Ellis Christopher Chief Operating Officer Officer
Transaction date
Sale
Price
4.78
Quantity 2,200 -96.7%
Value US$10,513
4.0
Griffiths Graham Chief Business Officer Officer
Transaction date
Sale
Price
4.75
Quantity 2,400 -2.0%
Value US$11,407
4.0
Ellis Christopher Chief Operating Officer Officer
Transaction date
Sale
Price
4.76
Quantity 5,350 -98.6%
Value US$25,463
4.0
Griffiths Graham Chief Business Officer Officer
Transaction date
Sale
Price
4.50
Quantity 5,000 -4.1%
Value US$22,500
4.0
Ellis Christopher Chief Operating Officer Officer
Transaction date
Sale
Price
6.00
Quantity 5 -6.2%
Value US$30
4.0
Griffiths Graham Chief Business Officer Officer
Transaction date
Sale
Price
5.28
Quantity 8 -0.0%
Value US$42
2.0
Scheeren Joseph Non-Executive Director
Transaction date
Purchase
Price
5.09
Quantity 10,000 +333.3%
Value US$50,900
1.0
Hammacher Alex Non-Executive Director
Transaction date
Purchase
Price
5.14
Quantity 2,000 +200.0%
Value US$10,280
1.0
Hammacher Alex Non-Executive Director
Transaction date
Purchase
Price
10.86
Quantity 1,000 +inf%
Value US$10,860
1.1
Wright Robin Non-Executive Director
Transaction date
Purchase
Price
9.97
Quantity 10,000 +40.8%
Value US$99,700
2.0
Scheeren Joseph Non-Executive Director
Transaction date
Purchase
Price
17.00
Quantity 3,000 +inf%
Value US$51,000
2.5
DAWES KAREN A Non-Executive Director
Transaction date
Purchase
Price
17.00
Quantity 1,700 +inf%
Value US$28,900
Phillips Anne M. Non-Executive Director
Transaction date
Purchase
Price
17.00
Quantity 3,000 +inf%
Value US$51,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-28 2023-06-26 B Purchase
2.0
Scheeren Joseph
Non-Executive Director
6,091 -25.3%
226.61
US$3,306,075 		6,091 -25.3% 226.61 US$3,306,075
2023-06-01 2023-05-25 B Purchase
1.1
Wright Robin
Non-Executive Director
22,569 +17.7%
478.44
US$4,845,817 		22,569 +17.7% 478.44 US$4,845,817
2023-03-29 2023-03-27 S Sale
2.2
Enright William

Chief Executive Officer

Executive Director
5,740 +43.8%
118.49
US$4,293,377 		5,740 +43.8% 118.49 US$4,293,377
2022-08-26 2022-08-25 S Sale
4.0
Ellis Christopher

Chief Operating Officer

Officer
25,000 -99.7%
7.07
US$176,708 		25,000 -99.7% 7.07 US$176,708
2022-08-26 2022-08-25 S Sale
4.0
Ellis Christopher

Chief Operating Officer

Officer
14,176 -36.1%
5.69
US$80,688 		14,176 -36.1% 5.69 US$80,688
2022-08-26 2022-08-25 S Sale
4.0
Griffiths Graham

Chief Business Officer

Officer
10,000 -8.8%
7.39
US$73,870 		10,000 -8.8% 7.39 US$73,870
2022-08-26 2022-08-24 S Sale
4.0
Ellis Christopher

Chief Operating Officer

Officer
450 -85.7%
4.78
US$2,152 		450 -85.7% 4.78 US$2,152
2022-08-19 2022-08-18 S Sale
4.0
Ellis Christopher

Chief Operating Officer

Officer
2,175 -96.7%
4.84
US$10,531 		2,175 -96.7% 4.84 US$10,531
2022-08-19 2022-08-17 S Sale
4.0
Ellis Christopher

Chief Operating Officer

Officer
649 -89.6%
4.77
US$3,093 		649 -89.6% 4.77 US$3,093
2022-08-19 2022-08-17 S Sale
4.0
Griffiths Graham

Chief Business Officer

Officer
500 -0.4%
4.76
US$2,381 		500 -0.4% 4.76 US$2,381
2022-08-17 2022-08-16 S Sale
4.0
Griffiths Graham

Chief Business Officer

Officer
1,220 -1.1%
4.82
US$5,876 		1,220 -1.1% 4.82 US$5,876
2022-08-17 2022-08-16 S Sale
4.0
Ellis Christopher

Chief Operating Officer

Officer
2,200 -96.7%
4.78
US$10,513 		2,200 -96.7% 4.78 US$10,513
2022-08-17 2022-08-15 S Sale
4.0
Griffiths Graham

Chief Business Officer

Officer
2,400 -2.0%
4.75
US$11,407 		2,400 -2.0% 4.75 US$11,407
2022-08-17 2022-08-15 S Sale
4.0
Ellis Christopher

Chief Operating Officer

Officer
5,350 -98.6%
4.76
US$25,463 		5,350 -98.6% 4.76 US$25,463
2022-08-15 2022-08-12 S Sale
4.0
Griffiths Graham

Chief Business Officer

Officer
5,000 -4.1%
4.50
US$22,500 		5,000 -4.1% 4.50 US$22,500
2022-07-15 2022-06-28 S Sale
4.0
Ellis Christopher

Chief Operating Officer

Officer
5 -6.2%
6.00
US$30 		5 -6.2% 6.00 US$30
2022-07-15 2022-06-23 S Sale
4.0
Griffiths Graham

Chief Business Officer

Officer
8 -0.0%
5.28
US$42 		8 -0.0% 5.28 US$42
2022-04-04 2022-04-01 B Purchase
2.0
Scheeren Joseph
Non-Executive Director
10,000 +333.3%
5.09
US$50,900 		10,000 +333.3% 5.09 US$50,900
2022-04-04 2022-03-31 B Purchase
1.0
Hammacher Alex
Non-Executive Director
2,000 +200.0%
5.14
US$10,280 		2,000 +200.0% 5.14 US$10,280
2022-01-04 2021-12-31 B Purchase
1.0
Hammacher Alex
Non-Executive Director
1,000 +inf%
10.86
US$10,860 		1,000 +inf% 10.86 US$10,860
2021-12-23 2021-12-22 B Purchase
1.1
Wright Robin
Non-Executive Director
10,000 +40.8%
9.97
US$99,700 		10,000 +40.8% 9.97 US$99,700
2021-05-06 2021-05-04 B Purchase
2.0
Scheeren Joseph
Non-Executive Director
3,000 +inf%
17.00
US$51,000 		3,000 +inf% 17.00 US$51,000
2021-05-06 2021-05-04 B Purchase
2.5
DAWES KAREN A
Non-Executive Director
1,700 +inf%
17.00
US$28,900 		1,700 +inf% 17.00 US$28,900
2021-05-06 2021-05-04 B Purchase
Phillips Anne M.
Non-Executive Director
3,000 +inf%
17.00
US$51,000 		3,000 +inf% 17.00 US$51,000
2021-05-06 2021-05-04 B Purchase
Oxford Sciences Innovation plc
Large shareholder
600,000 +7.3%
17.00
US$10,200,000 		600,000 +7.3% 17.00 US$10,200,000
2021-05-03 2021-04-30 B Purchase
3.7
M&G INVESTMENT MANAGEMENT LTD
Large shareholder
125,000 +13.0%
14.40
US$1,800,000 		125,000 +13.0% 14.40 US$1,800,000
Explore more

More insider trading research around Barinthus Biotherapeutics PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe